JetBlue Casts Doubt on $3.8 Billion Merger with Spirit Airlines as Sunday Deadline Looms
JetBlue Airways has thrown the future of its $3.8 billion merger deal with Spirit Airlines into uncertainty by suggesting it may not be able to meet certain conditions required as part of the agreement. The airline announced on Friday that, due to unspecified reasons, it has informed Spirit that the merger agreement might be terminated as early as Sunday.
This announcement has sent shockwaves through the market, with shares of Spirit Airlines plunging 9.5% to $6.54 on Friday afternoon. This comes on the heels of a tumultuous month for Spirit, during which its stock has witnessed losses of about 55%, triggered by a U.S. judge’s decision to block the merger deal.
In response to JetBlue’s statement, Spirit Airlines countered that there is no valid basis for terminating the merger agreement. The low-cost carrier emphasized its commitment to fulfilling its obligations under the agreement and expects JetBlue to do the same.
Without the JetBlue deal, Spirit Airlines faces a challenging road ahead. The ultra-low-cost carrier has been grappling with weak demand in its key markets as it strives to return to sustainable profitability. Some industry analysts have even speculated that the company could face bankruptcy if it fails to secure its finances.
Read more: JetBlue Urges Federal Court Approval for Spirit Airlines Acquisition
Spirit has been actively exploring options to refinance its 2025 debt maturities but maintains that it is not pursuing or involved in a statutory restructuring. Last week, the airline disclosed that compensation from supplier Pratt & Whitney for several grounded jets would be a significant source of liquidity over the next few years.
The merger hit a major roadblock earlier this month when a U.S. judge blocked the planned union with JetBlue, citing concerns that the proposed deal could threaten competition in the U.S. aviation market and harm ticket prices. Both JetBlue and Spirit have expressed their intent to appeal the ruling.
The deadline for the closure of the merger deal is January 28, according to the agreement. However, as of Friday, regulatory approval is still pending, and if not received by the deadline, an automatic provision extends the deadline until July 24, 2024. The fate of the deal now hangs in the balance as regulators continue to deliberate on its approval.
Source: WSJ
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan